Comparative Pharmacology
Head-to-head clinical analysis: MANNITOL 10 IN PLASTIC CONTAINER versus OSMITROL 10 IN WATER IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MANNITOL 10 IN PLASTIC CONTAINER versus OSMITROL 10 IN WATER IN PLASTIC CONTAINER.
MANNITOL 10% IN PLASTIC CONTAINER vs OSMITROL 10% IN WATER IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Mannitol is an osmotic diuretic that increases plasma osmolarity, drawing water from tissues into the bloodstream and enhancing water excretion by the kidneys. It also reduces intracranial pressure by creating an osmotic gradient across the blood-brain barrier.
Increases plasma osmolality, drawing water from tissues into the bloodstream, thereby reducing intracranial pressure and cerebral edema.
Adults: 50-100 g intravenously over 30-60 minutes, typically as a 15-25% solution. For reduction of intracranial pressure, 1.5-2 g/kg as a 20% solution IV over 30-60 minutes. For promotion of diuresis, 50-100 g as a 5-25% solution IV.
Initial: 0.25–1 g/kg (25–100 mL of 10% solution) IV over 30–60 minutes. May repeat every 6–12 hours if needed. Typical adult dose: 50–100 g IV. Maximum: 2 g/kg per dose.
None Documented
None Documented
Terminal elimination half-life is 0.25–1.5 hours; prolonged in renal impairment (up to 36 hours).
Terminal half-life approximately 1.5 hours in normal renal function; prolonged in renal impairment (up to 36 hours in anuria).
Renal: >90% as unchanged drug; minimal biliary or fecal excretion.
Primarily renal; >90% excreted unchanged in urine via glomerular filtration; <5% biliary/fecal.
Category A/B
Category C
Osmotic Diuretic
Osmotic Diuretic